behavior in the rat: level of n-6 fatty acids as another critical factor. J Lipid
Res 42:1655–1663.
Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM,
Coppola D, Morgan D, Gordon MN (2002) Microglial activation and
-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus
presenilin-1 transgenic mice. J Neurosci 22:2246 –2254.
Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM (1997)
Dietary fat intake and the risk of incident dementia in the Rotterdam
Study. Ann Neurol 42:776 –782.
Kalmijn S, van Boxtel MP, Ocke M, Verschuren WM, Kromhout D, Launer LJ
(2004) Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 62:275–280.
Kawarabayashi T, Shoji M, Younkin LH, Wen-Lang L, Dickson DW, Mu- rakami T, Matsubara E, Abe K, Ashe KH, Younkin SG (2004) Dimeric
amyloid protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse
model of Alzheimer's disease. J Neurosci 24:3801–3809.
Komatsu W, Ishihara K, Murata M, Saito H, Shinohara K (2003) Docosahexaenoic acid suppresses nitric oxide production and inducible nitric
oxide synthase expression in interferon-gamma plus lipopolysaccharidestimulated murine macrophages by inhibiting the oxidative stress. Free
Radic Biol Med 34:1006 –1016.
Kyle DJ, Schaefer E, Patton G, Beiser A (1999) Low serum docosahexaenoic
acid is a significant risk factor for Alzheimer's dementia. Lipids [Suppl]
34:S245.
Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C,
Fahrenholz F (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci USA 96:3922–3927.
Liang Y, Lin S, Beyer TP, Zhang Y, Wu X, Bales KR, DeMattos RB, May PC, Li
SD, Jiang XC, Eacho PI, Cao G, Paul SM (2004) A liver X receptor and
retinoid X receptor heterodimer mediates apolipoprotein E expression,
secretion and cholesterol homeostasis in astrocytes. J Neurochem
88:623– 634.
Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Hsiao
Ashe K, Frautschy SA, Cole GM (2000) Ibuprofen suppresses plaque
pathology and inflammation in a mouse model for Alzheimer's disease.
J Neurosci 20:5709 –5714.
Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (2001) The curry
spice curcumin reduces oxidative damage and amyloid pathology in an
Alzheimer transgenic mouse. J Neurosci 21:8370 – 8377.
Lopez-Perez E, Zhang Y, Frank SJ, Creemers J, Seidah N, Checler F (2001)
Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone
convertase 7 and the disintegrin metalloprotease ADAM10. J Neurochem
76:1532–1539.
Mitchell DC, Gawrisch K, Litman BJ, Salem Jr N (1998) Why is docosahexaenoic acid essential for nervous system function? Biochem Soc Trans
26:365–370.
Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ,
Morrow JD (2002) Lipid peroxidation in aging brain and Alzheimer's
disease. Free Radic Biol Med 33:620 – 626.
Moriguchi T, Salem Jr N (2003) Recovery of brain docosahexaenoate leads
to recovery of spatial task performance. J Neurochem 87:297–309.
Moriguchi T, Greiner RS, Salem Jr N (2000) Behavioral deficits associated
with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 75:2563–2573.
Moriguchi T, Loewke J, Garrison M, Catalan JN, Salem Jr N (2001) Reversal
of docosahexaenoic acid deficiency in the rat brain, retina, liver, and
serum. J Lipid Res 42:419 – 427.
Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS,
Aggarwal N, Schneider J (2003) Consumption of fish and n-3 fatty acids
and risk of incident Alzheimer disease. Arch Neurol 60:940 –946.
Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K,
Kholodenko D, Johnson-Wood K, McConlogue L (2000) High-level
neuronal expression of A 1– 42 in wild-type human amyloid protein
precursor transgenic mice: synaptotoxicity without plaque formation.
J Neurosci 20:4050 – 4058.
Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human ret-
